OR WAIT null SECS
September 21, 2015
Intuniv (guanfacine hydrochloride prolonged-release tablets) is the first selective alpha-2A adrenergic receptor agonist licensed for the treatment of attention deficit hyperactivity disorder in Europe.
September 16, 2015
The White House nominates Robert Califf to head FDA, but will he be confirmed?
September 15, 2015
President Obama will nominate Rob Califf, current deputy commissioner for medical products and tobacco, as FDA commissioner.
September 11, 2015
According to AstraZeneca, the purchase of the biologics bulk plant will double the company's biologics manufacturing capacity in the US.
September 08, 2015
The partners will collaborate on a project to capture and integrate clinical trial data metrics on investigational cancer medications.
September 03, 2015
Pfizer closes the acquisition of Hospira, adding sterile injectables business to portfolio.
September 02, 2015
The platform, developed by Vectron Biosolutions, will be used for BI’s in-house pipeline and for its outsourcing clients.
September 01, 2015
Under the terms of the agreement, Sartorius Stedim Biotech will manufacture membrane adsorber technologies for GE, which will be marketed as part of GE’s ReadyToProcess product offerings.
August 28, 2015
Growth is said to be driven by the deeper penetration of biosimilars in developed and emerging markets as a result of clearer regulatory pathways.
August 25, 2015
Pfizer agrees to divest four sterile injectable assets to clear the way to complete acquisition of Hospira.